These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

911 related items for PubMed ID: 32476787

  • 1. Folic acid attenuates high-fat diet-induced steatohepatitis via deacetylase SIRT1-dependent restoration of PPARα.
    Xin FZ, Zhao ZH, Zhang RN, Pan Q, Gong ZZ, Sun C, Fan JG.
    World J Gastroenterol; 2020 May 14; 26(18):2203-2220. PubMed ID: 32476787
    [Abstract] [Full Text] [Related]

  • 2. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R, Yu Y, Hu S, Zhang J, Yang H, Han B, Cheng Y, Luo X.
    Nutr Res; 2016 Sep 14; 36(9):1022-1030. PubMed ID: 27632923
    [Abstract] [Full Text] [Related]

  • 3. LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway.
    Chen XY, Cai CZ, Yu ML, Feng ZM, Zhang YW, Liu PH, Zeng H, Yu CH.
    World J Gastroenterol; 2019 Dec 07; 25(45):6607-6618. PubMed ID: 31832001
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
    Yang RX, Pan Q, Liu XL, Zhou D, Xin FZ, Zhao ZH, Zhang RN, Zeng J, Qiao L, Hu CX, Xu GW, Fan JG.
    Lipids Health Dis; 2019 Oct 21; 18(1):179. PubMed ID: 31639005
    [Abstract] [Full Text] [Related]

  • 5. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways.
    Li CX, Gao JG, Wan XY, Chen Y, Xu CF, Feng ZM, Zeng H, Lin YM, Ma H, Xu P, Yu CH, Li YM.
    World J Gastroenterol; 2019 Sep 14; 25(34):5120-5133. PubMed ID: 31558861
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A novel Alisma orientale extract alleviates non-alcoholic steatohepatitis in mice via modulation of PPARα signaling pathway.
    Xie Y, Jin Y, Wen J, Li G, Huai X, Duan Y, Ni F, Fu J, Li M, Li L, Yan M, Cao L, Xiao W, Yang H, Wang ZZ.
    Biomed Pharmacother; 2024 Jul 14; 176():116908. PubMed ID: 38850668
    [Abstract] [Full Text] [Related]

  • 8. Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism.
    Karimi-Sales E, Ebrahimi-Kalan A, Alipour MR.
    Biomed Pharmacother; 2019 Jan 14; 109():1306-1312. PubMed ID: 30551380
    [Abstract] [Full Text] [Related]

  • 9. Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats.
    Zhao ZH, Xin FZ, Zhou D, Xue YQ, Liu XL, Yang RX, Pan Q, Fan JG.
    World J Gastroenterol; 2019 May 28; 25(20):2450-2462. PubMed ID: 31171889
    [Abstract] [Full Text] [Related]

  • 10. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
    Chai C, Cox B, Yaish D, Gross D, Rosenberg N, Amblard F, Shemuelian Z, Gefen M, Korach A, Tirosh O, Lanton T, Link H, Tam J, Permyakova A, Ozhan G, Citrin J, Liao H, Tannous M, Hahn M, Axelrod J, Arretxe E, Alonso C, Martinez-Arranz I, Betés PO, Safadi R, Salhab A, Amer J, Tber Z, Mengshetti S, Giladi H, Schinazi RF, Galun E.
    Gastroenterology; 2020 Sep 28; 159(3):999-1014.e9. PubMed ID: 32450149
    [Abstract] [Full Text] [Related]

  • 11. Formononetin promotes fatty acid β-oxidation to treat non-alcoholic steatohepatitis through SIRT1/PGC-1α/PPARα pathway.
    Liao J, Xie X, Wang N, Wang Y, Zhao J, Chen F, Qu F, Wen W, Miao J, Cui H.
    Phytomedicine; 2024 Feb 28; 124():155285. PubMed ID: 38185065
    [Abstract] [Full Text] [Related]

  • 12. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M, Fukunishi S, Nakano T, Ueno T, Higuchi K, Asai A.
    mBio; 2021 Aug 31; 12(4):e0115521. PubMed ID: 34225483
    [Abstract] [Full Text] [Related]

  • 13. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
    Vitaglione P, Mazzone G, Lembo V, D'Argenio G, Rossi A, Guido M, Savoia M, Salomone F, Mennella I, De Filippis F, Ercolini D, Caporaso N, Morisco F.
    J Nutr Sci; 2019 Aug 31; 8():e15. PubMed ID: 31037218
    [Abstract] [Full Text] [Related]

  • 14. Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway.
    Huang Y, Lang H, Chen K, Zhang Y, Gao Y, Ran L, Yi L, Mi M, Zhang Q.
    Appl Physiol Nutr Metab; 2020 Mar 31; 45(3):227-239. PubMed ID: 31173696
    [Abstract] [Full Text] [Related]

  • 15. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism.
    Yin Y, Yu Z, Xia M, Luo X, Lu X, Ling W.
    Eur J Clin Invest; 2012 Nov 31; 42(11):1189-96. PubMed ID: 22958216
    [Abstract] [Full Text] [Related]

  • 16. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
    Zhou D, Pan Q, Xin FZ, Zhang RN, He CX, Chen GY, Liu C, Chen YW, Fan JG.
    World J Gastroenterol; 2017 Jan 07; 23(1):60-75. PubMed ID: 28104981
    [Abstract] [Full Text] [Related]

  • 17. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
    Li X, Wang Z, Klaunig JE.
    Toxicology; 2019 Mar 15; 416():1-14. PubMed ID: 30711707
    [Abstract] [Full Text] [Related]

  • 18. Dendrobium officinale alleviates high-fat diet-induced nonalcoholic steatohepatitis by modulating gut microbiota.
    Tian G, Wang W, Xia E, Chen W, Zhang S.
    Front Cell Infect Microbiol; 2023 Mar 15; 13():1078447. PubMed ID: 36860985
    [Abstract] [Full Text] [Related]

  • 19. The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats.
    Lin Z, Wu ZF, Jiang CH, Zhang QW, Ouyang S, Che CT, Zhang J, Yin ZQ.
    Phytomedicine; 2016 Nov 15; 23(12):1475-1483. PubMed ID: 27765368
    [Abstract] [Full Text] [Related]

  • 20. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D, Nistal E, Martínez-Flórez S, Pisonero-Vaquero S, Olcoz JL, Jover R, González-Gallego J, García-Mediavilla MV, Sánchez-Campos S.
    Free Radic Biol Med; 2017 Jan 15; 102():188-202. PubMed ID: 27890642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.